Posted inGeneral Surgery news Oncology
Efficacy of SI-449 Cross-Linked Chondroitin Sulfate Adhesion Barrier in Open Rectal Resection: A Landmark Randomized Trial
This randomized clinical trial demonstrates that SI-449, a novel cross-linked chondroitin sulfate powder, significantly reduces postoperative adhesions following open rectal cancer surgery, offering a safe and practical adhesion prevention option.